Metropolitan Life Insurance Company (MetLife)’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,637
| Closed | -$34.2K | – | 128 |
|
|
2024
Q1 | $34.2K | Sell |
5,637
-1,243
| -18% | -$7.53K | ﹤0.01% | 1591 |
|
|
2023
Q4 | $41.8K | Hold |
6,880
| – | – | ﹤0.01% | 1544 |
|
|
2023
Q3 | $29K | Buy |
6,880
+1,143
| +20% | +$4.82K | ﹤0.01% | 1699 |
|
|
2023
Q2 | $17.8K | Hold |
5,737
| – | – | ﹤0.01% | 1996 |
|
|
2023
Q1 | $7.97K | Sell |
5,737
-554
| -9% | -$770 | ﹤0.01% | 2226 |
|
|
2022
Q4 | $12.5K | Hold |
6,291
| – | – | ﹤0.01% | 2210 |
|
|
2022
Q3 | $12.7K | Buy |
6,291
+3,311
| +111% | +$6.69K | ﹤0.01% | 2222 |
|
|
2022
Q2 | $9.48K | Sell |
2,980
-3,369
| -53% | -$10.7K | ﹤0.01% | 2315 |
|
|
2022
Q1 | $26.5K | Sell |
6,349
-13,762
| -68% | -$57.4K | ﹤0.01% | 1957 |
|
|
2021
Q4 | $96.3K | Sell |
20,111
-4,448
| -18% | -$21.3K | ﹤0.01% | 2511 |
|
|
2021
Q3 | $131K | Sell |
24,559
-9,436
| -28% | -$50.4K | ﹤0.01% | 2365 |
|
|
2021
Q2 | $174K | Buy |
33,995
+5,361
| +19% | +$27.4K | ﹤0.01% | 2251 |
|
|
2021
Q1 | $193K | Buy |
28,634
+911
| +3% | +$6.13K | ﹤0.01% | 2042 |
|
|
2020
Q4 | $127K | Sell |
27,723
-3,779
| -12% | -$17.3K | ﹤0.01% | 2230 |
|
|
2020
Q3 | $122K | Sell |
31,502
-5,594
| -15% | -$21.7K | ﹤0.01% | 2102 |
|
|
2020
Q2 | $177K | Sell |
37,096
-1,286
| -3% | -$6.12K | ﹤0.01% | 1883 |
|
|
2020
Q1 | $134K | Sell |
38,382
-1,143
| -3% | -$3.98K | ﹤0.01% | 1848 |
|
|
2019
Q4 | $191K | Buy |
39,525
+20,066
| +103% | +$96.7K | ﹤0.01% | 1964 |
|
|
2019
Q3 | $56.4K | Sell |
19,459
-9,168
| -32% | -$26.6K | ﹤0.01% | 2487 |
|
|
2019
Q2 | $205K | Hold |
28,627
| – | – | ﹤0.01% | 1875 |
|
|
2019
Q1 | $406K | Hold |
28,627
| – | – | 0.01% | 1433 |
|
|
2018
Q4 | $387K | Hold |
28,627
| – | – | 0.01% | 1367 |
|
|
2018
Q3 | $635K | Buy |
+28,627
| New | +$635K | 0.01% | 1205 |
|